Cargando…

Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab

OBJECTIVE: To determine whether patients with inflammatory autoimmune diseases treated with rituximab (RTX) have more severe forms of COVID-19 compared with patients treated with anticytokine therapies, such as Tumour Necrosis Factor (TNF) inhibitors. METHODS: We included all patients who were on ei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melong Pianta Taleng, Cathy Mireille, Lauper, Kim, Gilbert, Benoit, Cunningham, Tim, Guemara, Romain, Brulhart, Laure, Dan, Diana, Courvoisier, Delphine, Finckh, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646967/ https://www.ncbi.nlm.nih.gov/pubmed/34862310 http://dx.doi.org/10.1136/rmdopen-2021-001711

Ejemplares similares

Angioinvasive aspergillosis mimicking giant cell arteritis in an 81-year-old man with jaw pain and vision loss
por: Guemara, Romain, et al.
Publicado: (2022)

Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab
por: Burkard, Theresa, et al.
Publicado: (2023)

Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
por: Mongin, Denis, et al.
Publicado: (2022)

PROLONGED COVID-19 IN PATIENTS TREATED WITH RITUXIMAB
por: WEBER, ANDREW, et al.
Publicado: (2021)

Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis
por: Gilbert, Benoit Thomas P, et al.
Publicado: (2021)

INCREASED RISK OF MECHANICAL VENTILATION AND DEATH IN PATIENTS WITH COVID-19 RECENTLY TREATED WITH RITUXIMAB
por: MILES, B., et al.
Publicado: (2022)

Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study
por: Lamacchia, Celine, et al.
Publicado: (2023)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Mini-Review: Human Microbiome and Rheumatic Diseases
por: Vural, Meltem, et al.
Publicado: (2020)

Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report
por: Kim, Seondeuk, et al.
Publicado: (2022)

Measuring ACPA in the general population or primary care: is it useful?
por: Finckh, Axel, et al.
Publicado: (2020)

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
por: Bitoun, Samuel, et al.
Publicado: (2022)

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
por: Finckh, A, et al.
Publicado: (2010)

Combined Infliximab and Rituximab in Necrotising Scleritis
por: Morarji, Jiten, et al.
Publicado: (2012)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases
por: Amend, Lena, et al.
Publicado: (2023)

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
por: Riek, Myriam, et al.
Publicado: (2023)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
por: Mongin, Denis, et al.
Publicado: (2019)

Reactivation of Bovine Tuberculosis in Patient Treated with Infliximab, Switzerland
por: Nager, Marina, et al.
Publicado: (2009)

Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
por: Kim, Bo Young, et al.
Publicado: (2017)

Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
por: Kim, Bo Young, et al.
Publicado: (2017)

Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab
por: Diarra, Ava, et al.
Publicado: (2021)

IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab
por: Font, Guillaume, et al.
Publicado: (2022)

PATIENT ON RITUXIMAB CONTRACTING COVID-19 VIRUS AFTER VACCINATION
por: KHAN, AWAB, et al.
Publicado: (2021)

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
por: Regierer, Anne Constanze, et al.
Publicado: (2021)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

Infliximab/rituximab: COVID-19 infection: 10 case reports
Publicado: (2022)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
por: Saffari, Fatemeh, et al.
Publicado: (2022)

SARS-COV-2 INFECTION WITH RITUXIMAB THERAPY
por: AUGENSTEIN, CHERYL, et al.
Publicado: (2022)

Targeting the Gut Microbiota to Treat Cachexia
por: Genton, Laurence, et al.
Publicado: (2019)

RELAPSE AND REMITTING COVID-19 INFECTIONS IN AN IMMUNOSUPPRESSED PATIENT ON CHRONIC RITUXIMAB INFUSIONS
por: GREWAL, SAHIB, et al.
Publicado: (2021)

Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis
por: Brulhart, Laure, et al.
Publicado: (2019)

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
por: Valdes, Lianna, et al.
Publicado: (2022)

Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction
por: Shaw, Yomei, et al.
Publicado: (2021)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
por: Stiegler, Julia D., et al.
Publicado: (2017)

Sarcoidosis secondary to lymphocyte active immunotherapy treated with infliximab
por: de Souza, Gabriela Higino, et al.
Publicado: (2018)

Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions
por: Marais, Ben J, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i32dr908pn22urjf11guvgjnpg